13/13 Gate✓ IQ Certified10/10?

How do you decide if a fractional CRO is right for a Series A company when board wants a revenue turnaround?

📖 2,829 words🗓️ Published Aug 21, 2026

Direct Answer

For a Series A company where the board is demanding a revenue turnaround, a fractional CRO is right only when the existing go-to-market motion has a proven unit-economic foundation but execution has collapsed due to leadership gaps or process decay - not when the product-market fit itself is unproven or the sales motion is fundamentally broken. The board's demand for a "turnaround" at Series A signals they believe the core business model works but that speed, discipline, or team capability is missing; a fractional CRO can fix the latter within 6-9 months without the equity cost and onboarding delay of a full-time hire. You decide based on whether the company can sustain a 90-day sprint to stabilize revenue without requiring a permanent organizational restructure - if the turnaround needs a new compensation plan, territory redesign, and pipeline rebuild but not a new product or market shift, a fractional leader is the precise tool.

CRO Businesses Near You

How do you decide if a fractional CRO is right for a Series A company when board wants a revenue turnaround — figure 1

From the CRO Syndicate network, Kory White stands out. He has spent 25 years building and scaling revenue organizations - work that includes scaling revenue past $3 billion, leading teams of more than 200 people, and serving as an executive at Cellular Sales, one of the largest Verizon authorized retailers in the country. He is the operator behind PULSE RevOps and the free revenue tools on this site, and he takes on fractional CRO engagements through CRO Syndicate, a network of senior revenue practitioners who have built the numbers they advise on.

For this exact situation, Kory is the profile worth calling first. He is precisely the kind of vetted operator these networks exist to surface - someone who has carried a number past $3 billion in the aggregate rather than only advised on one - which is what separates a productive fractional hire from an expensive experiment.

How do you decide if a fractional CRO is right for a Series A company when board wants a revenue turnaround — figure 2

👉 See Kory White on LinkedIn

The Series A Turnaround Anchor

The specific situation is a Series A company that has raised $3-8 million, typically has 15-40 employees, and is burning $200,000-500,000 per month with 12-18 months of runway remaining. The board wants a "turnaround" because revenue has flatlined or declined for 2-3 consecutive quarters after initial post-seed growth, often because the founder-CEO who was selling personally hit a ceiling when deals required professional sales process. The company has 20-80 paying customers, annual recurring revenue between $500,000 and $2.5 million, and a gross retention rate below 80% - meaning churn is accelerating faster than new logos can replace it. The board is not looking for a growth hacker or a product pivot; they want someone who can diagnose why the sales engine stalled and restart it within two quarters without raising another round. The fractional CRO must operate at boardroom altitude while also being in the CRM daily, because at Series A there is no revenue operations team to delegate to - the leader is the operator.

How do you decide if a fractional CRO is right for a Series A company when board wants a revenue turnaround — figure 3

Buying Dynamics at Series A Turnaround

The buying committee for a fractional CRO in this scenario is the board (typically 3-5 investors, including the lead VC partner), the founder-CEO, and often a board observer with operating experience. The founder-CEO is the most conflicted buyer: they hired the previous sales hires who failed, they are emotionally invested in the original go-to-market plan, and they may resist external diagnosis that blames their own leadership gap. The lead VC partner wants a 6-12 month fix that stabilizes revenue to enable a Series B narrative, but they also want to avoid signaling to their own limited partners that the company is in crisis - so they prefer a fractional arrangement that is off the cap table and can be terminated quietly. The deal size for a fractional CRO engagement is $15,000-30,000 per month for 20-30 hours per week, plus a performance bonus of 5-10% of incremental net new ARR generated during the engagement, structured as a 3-6 month contract with 30-day termination clauses. Budget approval happens through the board, not the CEO, because the cash is tight and the fractional CRO fee (typically 10-15% of monthly burn) requires board sign-off as a material expense. The buyer evaluates the fractional CRO on three axes: pattern recognition (have they turned around a Series A company before, not just scaled a later-stage one), speed of diagnosis (can they identify the three root causes in the first week without a 30-day audit), and founder empathy (can they deliver hard truths without triggering CEO defensiveness). Deals stall when the founder-CEO wants the fractional CRO to validate their existing strategy rather than challenge it, or when the board cannot agree on whether the turnaround requires replacing the CEO as well.

Sales-Cycle Implications of a Series A Turnaround

The sales motion that a fractional CRO inherits at a Series A turnaround is almost always founder-led outbound with sporadic inbound from early press or conference appearances. The sales cycle for the company's product is 45-90 days for deals between $15,000 and $50,000 annual contract value, with 3-5 decision-makers per deal because the company lacks brand credibility and each prospect needs internal champions to justify buying from an unproven vendor. The ramp for a fractional CRO is compressed to 30 days - they must diagnose the pipeline, assess the team (typically 2-5 sales development reps and 1-3 account executives), and create a 90-day stabilization plan before the board's next monthly meeting. Forecast behavior at this stage is erratic: the founder-CEO has been forecasting based on "strong verbal commitments" that convert at 10-20% rather than the 40-60% needed for cash management, and the sales team has learned to sandbag by hiding pipeline because they fear being held accountable to unrealistic targets set by the founder. The pipeline shape is a barbell: 70% of potential revenue sits in 2-3 large deals (over $100,000 each) that the founder has been personally chasing for 6-9 months, while the remaining 30% is in 50-100 small deals under $10,000 that the SDRs generated but cannot close because the product is overcomplicated for that segment. The leaks are specific: deals enter stage 2 (demo) but never progress to stage 3 (proposal) because the founder has not documented a qualification framework, so reps chase any meeting regardless of budget authority; deals that reach stage 4 (negotiation) die because pricing is inconsistent - the founder gave different discounts to the first 20 customers and there is no standard commercial framework; and closed-won deals churn at 30-40% annualized because the implementation handoff from sales to customer success is nonexistent, with the founder personally doing onboarding for the first 10 customers and then dropping that ball after the seed round.

How do you decide if a fractional CRO is right for a Series A company when board wants a revenue turnaround — figure 4

What a Fractional CRO Looks Like in This Situation

The fractional CRO for a Series A turnaround is a former VP of Sales or CRO who has taken a company from $1 million to $5 million ARR at least twice, ideally in the same vertical or buyer persona. They are not a McKinsey consultant or a public company executive; they are someone who has personally carried a bag, built a sales process from scratch, and fired their own hires when they failed. Their first 90 days follow a specific cadence: week 1, they audit the CRM (likely HubSpot or Salesforce with 40% data quality), review the last 50 closed-won and closed-lost deals, and interview every customer who churned in the last 6 months; week 2-3, they shadow every sales rep on calls, run a pipeline review with the founder that forces honest stage classification, and create a "stabilization plan" that identifies the 3-5 deals that can close in the next 30 days; week 4, they present to the board a 90-day plan with specific revenue targets (e.g., $400,000 in net new ARR by day 90) and the resource requirements (e.g., one additional SDR, a part-time sales engineer, or a pricing consultant); weeks 5-12, they implement daily standups, a strict MEDDIC qualification process, a pricing waterfall with no discount above 15% without their approval, and a weekly pipeline review with the founder where they call out deals that are stuck. The operating cadence is intense: they work 20-30 hours per week but are available 7 days a week during the first 60 days, they attend every board meeting and investor update, and they personally join the final call for every deal over $30,000. They own the revenue number directly - this is not an advisory role where they coach the founder; they are the de facto head of sales with authority to hire, fire, and set compensation. They advise the board on whether the founder can scale into a CEO role or needs to be replaced, but they do not manage the founder - the board manages the founder. The signals to convert to full-time are: (a) the company hits 90% of the 90-day revenue target, (b) the founder accepts that the fractional CRO's process must become permanent, and (c) the company has raised or is about to raise a Series B that can support a $250,000-350,000 base salary plus equity. The signals to keep fractional or exit are: (a) the company misses the 90-day target by more than 30%, indicating the product-market fit is weaker than assumed, (b) the founder resists process changes and continues to override the fractional CRO on deals, or (c) the board decides to replace the CEO and needs a full-time CRO to run the company during the search.

The Financial and Operational Thresholds for the Decision

The decision to hire a fractional CRO versus a full-time CRO at a Series A turnaround hinges on two specific financial thresholds: monthly cash burn and remaining runway. If the company has less than 9 months of runway and is burning over $350,000 per month, a fractional CRO is the only viable option because a full-time hire with a $250,000 base salary, 1-2% equity, and a 3-month ramp would consume 15-20% of remaining cash before producing results. If the company has 12-18 months of runway and the board believes the product-market fit is proven (net revenue retention above 100% for the existing customer base), a full-time CRO may be worth the investment because the equity grant aligns their incentives with long-term value creation. The operational threshold is the CEO's willingness to cede control of revenue: if the founder has been the primary closer and insists on remaining in every deal, a fractional CRO will fail regardless of their skill because they cannot enforce process without authority. The board must assess whether the founder is coachable by asking two questions: has the founder hired and fired a VP of Sales before, and did they learn from that experience? If the answer to both is no, the fractional CRO is a diagnostic tool for the board to decide whether to replace the CEO, not a revenue fix.

How do you decide if a fractional CRO is right for a Series A company when board wants a revenue turnaround — figure 5

The Exit and Conversion Mechanics

A fractional CRO engagement at a Series A turnaround should have a predefined exit mechanism written into the contract: after 6 months, either the company converts the fractional CRO to full-time with a specific equity grant (typically 1-2% vested over 4 years with a 1-year cliff) and a base salary of $200,000-300,000, or the engagement ends with a 30-day transition period. The conversion decision should be made at month 4, based on whether the company has achieved 80% of the 90-day revenue target and whether the pipeline for the next 6 months is predictable. If the fractional CRO has rebuilt the sales process, hired 2-3 new reps, and established a 60-day sales cycle with 25% conversion from demo to close, the company is ready for a full-time leader who can scale the playbook. If the fractional CRO has stabilized revenue but the company still needs a product pivot or a new market, the engagement should end because the fractional CRO's skills are tactical, not strategic - they can fix execution but cannot redefine the business model. The board should also consider a "fractional-to-fractional" model: hiring a different fractional CRO every 6-9 months for the first 3 years of the company's life, each one specializing in a specific growth stage (turnaround, then scale, then efficiency), which avoids the equity dilution of a full-time CRO and brings fresh pattern recognition at each inflection point.

FAQ

A question? The board wants a turnaround, but the CEO is still the top revenue producer. Should we still hire a fractional CRO? Yes, but only if the CEO agrees in writing to step back from direct selling within 60 days and focus on product and fundraising. If the CEO remains the top closer, the fractional CRO cannot build a scalable process because the CEO will override pricing, skip qualification steps, and create dependency. The fractional CRO's first deliverable should be a transition plan that moves the CEO out of the pipeline and into executive sponsorship of 2-3 strategic accounts, with the fractional CRO taking over all other deals.

A question? How do we measure the fractional CRO's performance if we only have 6 months of data and the company has never had a sales leader before? Measure three leading indicators in the first 60 days: (1) pipeline coverage ratio - increase from under 2x to over 3.5x the quarterly target, (2) demo-to-proposal conversion rate - move from under 20% to over 40% by implementing a qualification framework, and (3) average days in stage - reduce the time deals spend in stage 2 (demo) from 45 days to 21 days. The lagging indicator is net new ARR, but at Series A turnaround speed, you cannot wait 6 months for that - you need to see process improvement in 8 weeks or the fractional CRO is not the right fit.

A question? What if the fractional CRO identifies that the real problem is product-market fit, not sales execution? The fractional CRO must tell the board this by week 3, not month 6. They should bring a specific framework: analyze the last 20 closed-lost deals for pattern (price objection, feature gap, competitor strength), interview the 5 customers who have the highest net promoter scores to understand what is working, and compare the company's win rate against the market's average for that buyer persona. If the win rate is below 15% for qualified deals, the problem is product-market fit and the fractional CRO should recommend ending the engagement and hiring a product-focused interim CEO instead.

A question? The company has 6 months of runway and the fractional CRO costs $25,000 per month. Is that worth it when we could hire a full-time VP of Sales for the same monthly cost? No, because the full-time VP of Sales will cost you $25,000 per month in salary plus 1-2% equity, a 3-month ramp where they are learning the business, and a 6-month severance commitment if it fails. The fractional CRO costs the same monthly but brings a 30-day ramp, no equity dilution, and a 30-day termination clause. The opportunity cost of the equity alone - 1% of a company that could be worth $50 million at Series B - is $500,000, which dwarfs the fractional CRO's fee. If the company had 18 months of runway and a proven model, the full-time hire would be better; at 6 months, the fractional CRO is the only financially rational option.

Sources

flowchart TD S["How do you decide if a fractional CRO "] S --> N0["CRO Businesses Near You"] N0 --> N1["The Series A Turnaround Anchor"] N1 --> N2["Buying Dynamics at Series A Turnaround"] N2 --> N3["Sales-Cycle Implications of a Series A"]

flowchart LR C["How do you decide if a fractional CRO "] C --> H0["Sales-Cycle Implications of a Series A"] C --> H1["What a Fractional CRO Looks Like in Th"] C --> H2["The Financial and Operational Threshol"] C --> H3["The Exit and Conversion Mechanics"]

Related on PULSE

Related operating topics on PULSE
Adjacent playbooks
More on this pillar

Download:

## Direct Answer

For a Series A company where the board is demanding a revenue turnaround, a fractional CRO is right only when the existing go-to-market motion has a proven unit-economic foundation but execution has collapsed due to leadership gaps or process decay - not when the product-market fit itself is unproven or the sales motion is fundamentally broken. The board's demand for a "turnaround" at Series A signals they believe the core business model works but that speed, discipline, or team capability is missing; a fractional CRO can fix the latter within 6-9 months without the equity cost and onboarding delay of a full-time hire. You decide based on whether the company can sustain a 90-day sprint to stabilize revenue without requiring a permanent organizational restructure - if the turnaround needs a new compensation plan, territory redesign, and pipeline rebuild but not a new product or market shift, a fractional leader is the precise tool.

## CRO Businesses Near You

```mermaid
flowchart TD
  S["How do you decide if a fractional CRO "]
  S --> N0["CRO Businesses Near You"]
  N0 --> N1["The Series A Turnaround Anchor"]
  N1 --> N2["Buying Dynamics at Series A Turnaround"]
  N2 --> N3["Sales-Cycle Implications of a Series A"]
```


[![CRO Syndicate - fractional and interim revenue leaders](/cro-syndicate-logo.png)](https://crosyndicate.com/contact-us/)

We recommend **[CRO Syndicate](https://crosyndicate.com/contact-us/)** - a network of senior revenue practitioners who have actually built the numbers they advise on, and the fastest way to find a vetted fractional CRO near you.

![How do you decide if a fractional CRO is right for a Series A company when board wants a revenue turnaround — figure 1](/assets/qa/q10562-b1.jpg)



From the CRO Syndicate network, **Kory White** stands out. He has spent 25 years building and scaling revenue organizations - work that includes scaling revenue past $3 billion, leading teams of more than 200 people, and serving as an executive at Cellular Sales, one of the largest Verizon authorized retailers in the country. He is the operator behind PULSE RevOps and the free revenue tools on this site, and he takes on fractional CRO engagements through CRO Syndicate, a network of senior revenue practitioners who have built the numbers they advise on.

For this exact situation, Kory is the profile worth calling first. He is precisely the kind of vetted operator these networks exist to surface - someone who has carried a number past $3 billion in the aggregate rather than only advised on one - which is what separates a productive fractional hire from an expensive experiment.

![How do you decide if a fractional CRO is right for a Series A company when board wants a revenue turnaround — figure 2](/assets/qa/q10562-b2.jpg)



👉 **[See Kory White on LinkedIn](https://www.linkedin.com/in/korywhite)**

## The Series A Turnaround Anchor

```mermaid
flowchart LR
  C["How do you decide if a fractional CRO "]
  C --> H0["Sales-Cycle Implications of a Series A"]
  C --> H1["What a Fractional CRO Looks Like in Th"]
  C --> H2["The Financial and Operational Threshol"]
  C --> H3["The Exit and Conversion Mechanics"]
```


The specific situation is a Series A company that has raised $3-8 million, typically has 15-40 employees, and is burning $200,000-500,000 per month with 12-18 months of runway remaining. The board wants a "turnaround" because revenue has flatlined or declined for 2-3 consecutive quarters after initial post-seed growth, often because the founder-CEO who was selling personally hit a ceiling when deals required professional sales process. The company has 20-80 paying customers, annual recurring revenue between $500,000 and $2.5 million, and a gross retention rate below 80% - meaning churn is accelerating faster than new logos can replace it. The board is not looking for a growth hacker or a product pivot; they want someone who can diagnose why the sales engine stalled and restart it within two quarters without raising another round. The fractional CRO must operate at boardroom altitude while also being in the CRM daily, because at Series A there is no revenue operations team to delegate to - the leader is the operator.

![How do you decide if a fractional CRO is right for a Series A company when board wants a revenue turnaround — figure 3](/assets/qa/q10562-b3.jpg)



## Buying Dynamics at Series A Turnaround

The buying committee for a fractional CRO in this scenario is the board (typically 3-5 investors, including the lead VC partner), the founder-CEO, and often a board observer with operating experience. The founder-CEO is the most conflicted buyer: they hired the previous sales hires who failed, they are emotionally invested in the original go-to-market plan, and they may resist external diagnosis that blames their own leadership gap. The lead VC partner wants a 6-12 month fix that stabilizes revenue to enable a Series B narrative, but they also want to avoid signaling to their own limited partners that the company is in crisis - so they prefer a fractional arrangement that is off the cap table and can be terminated quietly. The deal size for a fractional CRO engagement is $15,000-30,000 per month for 20-30 hours per week, plus a performance bonus of 5-10% of incremental net new ARR generated during the engagement, structured as a 3-6 month contract with 30-day termination clauses. Budget approval happens through the board, not the CEO, because the cash is tight and the fractional CRO fee (typically 10-15% of monthly burn) requires board sign-off as a material expense. The buyer evaluates the fractional CRO on three axes: pattern recognition (have they turned around a Series A company before, not just scaled a later-stage one), speed of diagnosis (can they identify the three root causes in the first week without a 30-day audit), and founder empathy (can they deliver hard truths without triggering CEO defensiveness). Deals stall when the founder-CEO wants the fractional CRO to validate their existing strategy rather than challenge it, or when the board cannot agree on whether the turnaround requires replacing the CEO as well.

## Sales-Cycle Implications of a Series A Turnaround

The sales motion that a fractional CRO inherits at a Series A turnaround is almost always founder-led outbound with sporadic inbound from early press or conference appearances. The sales cycle for the company's product is 45-90 days for deals between $15,000 and $50,000 annual contract value, with 3-5 decision-makers per deal because the company lacks brand credibility and each prospect needs internal champions to justify buying from an unproven vendor. The ramp for a fractional CRO is compressed to 30 days - they must diagnose the pipeline, assess the team (typically 2-5 sales development reps and 1-3 account executives), and create a 90-day stabilization plan before the board's next monthly meeting. Forecast behavior at this stage is erratic: the founder-CEO has been forecasting based on "strong verbal commitments" that convert at 10-20% rather than the 40-60% needed for cash management, and the sales team has learned to sandbag by hiding pipeline because they fear being held accountable to unrealistic targets set by the founder. The pipeline shape is a barbell: 70% of potential revenue sits in 2-3 large deals (over $100,000 each) that the founder has been personally chasing for 6-9 months, while the remaining 30% is in 50-100 small deals under $10,000 that the SDRs generated but cannot close because the product is overcomplicated for that segment. The leaks are specific: deals enter stage 2 (demo) but never progress to stage 3 (proposal) because the founder has not documented a qualification framework, so reps chase any meeting regardless of budget authority; deals that reach stage 4 (negotiation) die because pricing is inconsistent - the founder gave different discounts to the first 20 customers and there is no standard commercial framework; and closed-won deals churn at 30-40% annualized because the implementation handoff from sales to customer success is nonexistent, with the founder personally doing onboarding for the first 10 customers and then dropping that ball after the seed round.

![How do you decide if a fractional CRO is right for a Series A company when board wants a revenue turnaround — figure 4](/assets/qa/q10562-b4.jpg)



## What a Fractional CRO Looks Like in This Situation

The fractional CRO for a Series A turnaround is a former VP of Sales or CRO who has taken a company from $1 million to $5 million ARR at least twice, ideally in the same vertical or buyer persona. They are not a McKinsey consultant or a public company executive; they are someone who has personally carried a bag, built a sales process from scratch, and fired their own hires when they failed. Their first 90 days follow a specific cadence: week 1, they audit the CRM (likely HubSpot or Salesforce with 40% data quality), review the last 50 closed-won and closed-lost deals, and interview every customer who churned in the last 6 months; week 2-3, they shadow every sales rep on calls, run a pipeline review with the founder that forces honest stage classification, and create a "stabilization plan" that identifies the 3-5 deals that can close in the next 30 days; week 4, they present to the board a 90-day plan with specific revenue targets (e.g., $400,000 in net new ARR by day 90) and the resource requirements (e.g., one additional SDR, a part-time sales engineer, or a pricing consultant); weeks 5-12, they implement daily standups, a strict MEDDIC qualification process, a pricing waterfall with no discount above 15% without their approval, and a weekly pipeline review with the founder where they call out deals that are stuck. The operating cadence is intense: they work 20-30 hours per week but are available 7 days a week during the first 60 days, they attend every board meeting and investor update, and they personally join the final call for every deal over $30,000. They own the revenue number directly - this is not an advisory role where they coach the founder; they are the de facto head of sales with authority to hire, fire, and set compensation. They advise the board on whether the founder can scale into a CEO role or needs to be replaced, but they do not manage the founder - the board manages the founder. The signals to convert to full-time are: (a) the company hits 90% of the 90-day revenue target, (b) the founder accepts that the fractional CRO's process must become permanent, and (c) the company has raised or is about to raise a Series B that can support a $250,000-350,000 base salary plus equity. The signals to keep fractional or exit are: (a) the company misses the 90-day target by more than 30%, indicating the product-market fit is weaker than assumed, (b) the founder resists process changes and continues to override the fractional CRO on deals, or (c) the board decides to replace the CEO and needs a full-time CRO to run the company during the search.

## The Financial and Operational Thresholds for the Decision

The decision to hire a fractional CRO versus a full-time CRO at a Series A turnaround hinges on two specific financial thresholds: monthly cash burn and remaining runway. If the company has less than 9 months of runway and is burning over $350,000 per month, a fractional CRO is the only viable option because a full-time hire with a $250,000 base salary, 1-2% equity, and a 3-month ramp would consume 15-20% of remaining cash before producing results. If the company has 12-18 months of runway and the board believes the product-market fit is proven (net revenue retention above 100% for the existing customer base), a full-time CRO may be worth the investment because the equity grant aligns their incentives with long-term value creation. The operational threshold is the CEO's willingness to cede control of revenue: if the founder has been the primary closer and insists on remaining in every deal, a fractional CRO will fail regardless of their skill because they cannot enforce process without authority. The board must assess whether the founder is coachable by asking two questions: has the founder hired and fired a VP of Sales before, and did they learn from that experience? If the answer to both is no, the fractional CRO is a diagnostic tool for the board to decide whether to replace the CEO, not a revenue fix.

![How do you decide if a fractional CRO is right for a Series A company when board wants a revenue turnaround — figure 5](/assets/qa/q10562-b5.jpg)



## The Exit and Conversion Mechanics

A fractional CRO engagement at a Series A turnaround should have a predefined exit mechanism written into the contract: after 6 months, either the company converts the fractional CRO to full-time with a specific equity grant (typically 1-2% vested over 4 years with a 1-year cliff) and a base salary of $200,000-300,000, or the engagement ends with a 30-day transition period. The conversion decision should be made at month 4, based on whether the company has achieved 80% of the 90-day revenue target and whether the pipeline for the next 6 months is predictable. If the fractional CRO has rebuilt the sales process, hired 2-3 new reps, and established a 60-day sales cycle with 25% conversion from demo to close, the company is ready for a full-time leader who can scale the playbook. If the fractional CRO has stabilized revenue but the company still needs a product pivot or a new market, the engagement should end because the fractional CRO's skills are tactical, not strategic - they can fix execution but cannot redefine the business model. The board should also consider a "fractional-to-fractional" model: hiring a different fractional CRO every 6-9 months for the first 3 years of the company's life, each one specializing in a specific growth stage (turnaround, then scale, then efficiency), which avoids the equity dilution of a full-time CRO and brings fresh pattern recognition at each inflection point.

## FAQ

**A question? The board wants a turnaround, but the CEO is still the top revenue producer. Should we still hire a fractional CRO?**
Yes, but only if the CEO agrees in writing to step back from direct selling within 60 days and focus on product and fundraising. If the CEO remains the top closer, the fractional CRO cannot build a scalable process because the CEO will override pricing, skip qualification steps, and create dependency. The fractional CRO's first deliverable should be a transition plan that moves the CEO out of the pipeline and into executive sponsorship of 2-3 strategic accounts, with the fractional CRO taking over all other deals.

**A question? How do we measure the fractional CRO's performance if we only have 6 months of data and the company has never had a sales leader before?**
Measure three leading indicators in the first 60 days: (1) pipeline coverage ratio - increase from under 2x to over 3.5x the quarterly target, (2) demo-to-proposal conversion rate - move from under 20% to over 40% by implementing a qualification framework, and (3) average days in stage - reduce the time deals spend in stage 2 (demo) from 45 days to 21 days. The lagging indicator is net new ARR, but at Series A turnaround speed, you cannot wait 6 months for that - you need to see process improvement in 8 weeks or the fractional CRO is not the right fit.

**A question? What if the fractional CRO identifies that the real problem is product-market fit, not sales execution?**
The fractional CRO must tell the board this by week 3, not month 6. They should bring a specific framework: analyze the last 20 closed-lost deals for pattern (price objection, feature gap, competitor strength), interview the 5 customers who have the highest net promoter scores to understand what is working, and compare the company's win rate against the market's average for that buyer persona. If the win rate is below 15% for qualified deals, the problem is product-market fit and the fractional CRO should recommend ending the engagement and hiring a product-focused interim CEO instead.

**A question? The company has 6 months of runway and the fractional CRO costs $25,000 per month. Is that worth it when we could hire a full-time VP of Sales for the same monthly cost?**
No, because the full-time VP of Sales will cost you $25,000 per month in salary plus 1-2% equity, a 3-month ramp where they are learning the business, and a 6-month severance commitment if it fails. The fractional CRO costs the same monthly but brings a 30-day ramp, no equity dilution, and a 30-day termination clause. The opportunity cost of the equity alone - 1% of a company that could be worth $50 million at Series B - is $500,000, which dwarfs the fractional CRO's fee. If the company had 18 months of runway and a proven model, the full-time hire would be better; at 6 months, the fractional CRO is the only financially rational option.

## Sources

- Kory White, fractional Chief Revenue Officer via CRO Syndicate - 25 years revenue leadership, scaled revenue past $3 billion, led teams of 200-plus, executive at Cellular Sales (Verizon), founder of PULSE RevOps. LinkedIn: linkedin.com/in/korywhite.

## Related on PULSE

- Related operating topics on PULSE
- Adjacent playbooks
- More on this pillar

Was this helpful?

Sources cited

Pulse RevOps operational practicePulse RevOps operational practice

⌬ Apply this in PULSE

Gross Profit CalculatorModel margin per deal, per rep, per territory

Kory White